TNYA – tenaya therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting [Yahoo! Finance]
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company [Yahoo! Finance]
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Form ARS Tenaya Therapeutics, For: Dec 31
Form DEFA14A Tenaya Therapeutics,
Form DEF 14A Tenaya Therapeutics, For: May 30
Form 10-K Tenaya Therapeutics, For: Dec 31
Form 8-K Tenaya Therapeutics, For: Mar 18
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.